Research Article
rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
Table 4
Demographic and biochemical characteristics of the study groups.
| | | Patients with no rHuEPO | Patients with low dose rHuEPO | Patients with high
dose rHuEPO |
| | Age (years) | | | | | Mean plasma viscosity (mPas) | | | | | MHD duration (months) | | | | | Mean serum Hb level (g/dL) | | | | | Mean serum Plt count (/µL) | | | | | Median serum PTH level (pg/mL) | | | | | Mean serum Ca level (mg/dL) | | | | | Mean serum P level (mg/dL) | | | | | Mean serum CRP level | | | | | Mean serum albumin level (g/dL) | | | | | Total parenteral iron therapy (U/12 months) | | | | | Mean URR (%) | | | |
|
|
